Semaglutide reduces vascular resistance and prevents fibrosis in kidneys of people with type 2 diabetes and chronic kidney disease, as shown by secondary outcomes.
- Open access
Moving in bioRxiv, Nature Medicine, Blood, Communications Biology, Nature reviews. Gastroenterology & hepatology and Plant Physiology and Biochemistry.
Rebuilt
Nothing in this topic has moved yet this week.
Newest first · last 60 days
Semaglutide reduces vascular resistance and prevents fibrosis in kidneys of people with type 2 diabetes and chronic kidney disease, as shown by secondary outcomes.
Calcium phosphate microdeposition linked to increased aortic dissection risk, driven by tissue nonspecific alkaline phosphatase activity in mice and humans.
OsPHO2 promotes ubiquitin-dependent degradation of OsHMGB1, regulating phosphate homeostasis in rice by controlling PSR gene expression.
Erythroid-produced intact FGF23 acts as a paracrine inhibitor of erythropoiesis, contributing to anemia in mice models of iron deficiency and chronic kidney disease.
Journals this month
Topics moving, week to 23 Oct 2026